Las Vegas, NV -- (SBWIRE) -- 07/20/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Globalstar, Inc. (OTCMKTS:GSAT), Affymax, Inc. (OTCMKTS:AFFY), Arch Therapeutics Inc (OTCBB:ARTH), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY)
Globalstar, Inc. (OTCMKTS:GSAT) gained 0.79%, trading on 1.31 million shares to end the trade at $0.635. If we look at its trading history of past 52 weeks, the share price suffered low of $0.25 and was moved to maximum level of $0.69.The stock changed hands in a range of $0.63 to $0.64, bringing its market capitalization at about $312.56 million. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications; fixed voice and data satellite communications services in rural villages.
For How Long GSAT will fight for Profitability? Read This Trend Analysis report
Affymax, Inc. (OTCMKTS:AFFY) declined -4.24% to complete the trading session at $1.13 with a total volume of 683,830shares.The stock, on average, trades on a volume of 1.31 million shares. In the past 52 weeks, the share price has not declined below $0.78 and above $27.74.It floated in a range of $1.10 to $1.19 during last trading session with a beta value of 1.28.Its market capitalization now moved to about $42.36 million. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Has AFFY Found The Bottom and Ready To Move Up? Find Out Here
Arch Therapeutics Inc (OTCBB:ARTH) added 6.22% and was in a range of $0.44-$0.51 before closing at $0.478. The share price hit its 52-week low of $0.01 and $1.36 was the best price. The stock completed the day with a total volume of 1.52 million shares versus an average volume of 1.63 million shares. Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding. The company was formerly known as Clear Nano Solutions, Inc. It was founded in 2006 and is based in Natick, Massachusetts.
What was the Moving Force behind ARTH on Bullish Run? Read This Research Report
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) declined -0.66% yesterday, bringing its market capitalization around $3.35 billion. The total number of shares changed hands during the session was 66,745 shares as compared to average trading volume of 149,072 shares. The share price after opening at $9.26 made a high of $9.26 and hovered above $9.00 to end the day at $9.01. Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services, information technology (IT) services, and network services in New Zealand and Australia.
Has NZTCY Found The Bottom And Ready To Gain Momentum? Find Out Here
About Value Stock Pick
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)